IP Library Granted Patent US 7,470,661
Granted Patent B2
US 7,470,661 · App. 11/062,471 · Granted Dec 30, 2008

Delivery of superoxide dismutase to neuronal cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,470,661
App. No.
11/062,471
Granted
Dec 30, 2008
Kind
B2
Abstract

A composition for delivery of superoxide dismutase to neuronal cells comprise a superoxide dismutase linked by a linker to a neuronal cell targeting component, which component comprises a first domain that binds to a neuronal cell and a second domain that translocates the superoxide dimutase into the neuronal cell. After translocation, the linker is cleaved to release superoxide dimutase from the neuronal cell targeting domain. Also described is use of the composition for treatment of oxidative damage to neuronal cells and further targeting of the composition using human mitochondrial leader sequences. A hybrid polypeptide is described that contains a bacterial superoxide dismutase plus a sequence that targets a human mitochondira.

Claims (9)

1. A conjugate for delivery of superoxide dismutase (SOD) to a mitochondrion in a neuronal cell, comprising:

(i) SOD and a leader sequence, wherein said leader sequence targets the SOD to said mitochondrion; and

(ii) a neuronal cell targeting component,

wherein said neuronal cell targeting component is linked to the SOD by a cleavable linker selected from the group consisting of (a) a disulfide bridge, and (b) a site for a protease found in neuronal cells,

and wherein said neuronal targeting component comprises a first domain that binds to a neuronal cell, wherein said first domain comprises a clostridial neurotoxin cell binding domain, and a clostridial neurotoxin translocation domain that translocates the SOD into said neuronal cell.

2. The conjugate of claim 1 , wherein the first domain comprises a H C fragment of a clostridial neurotoxin H-chain.

3. The conjugate of claim 1 , wherein the clostridial neurotoxin translocation domain comprises a H N fragment of a clostridial neurotoxin H-chain.

4. The conjugate of claim 1 , wherein the SOD is Mn-SOD.

5. The conjugate of claim 1 , wherein the leader sequence that targets the SOD to the mitochondrion is derived from human Mn-SOD.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2007
From: HEALTH PROTECTION AGENCY
To: SYNTAXIN LIMITED
Reel/Frame 019984/0225 →
CHANGE OF NAME Recorded Jul 1, 2005
From: MICROBIOLOGICAL RESEARCH AUTHORITY
To: HEALTH PROTECTION AGENCY
Reel/Frame 016213/0602 →